No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Javed Butler, MD
PeerMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Daniel Gaudet, MD, PhD
PeerStopping aspirin after 1 month DAPT in ACS patients after stenting
Gregg Stone, MD
PeerInflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
The Gene Messenger: Advancing Neurological Gene Therapy
Michael Kaplitt, MD, PhD
PeerThe Network Effect: Analyzing Brain Structures to Treat Depression
Conor Liston, MD, PhD
PeerMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Daniel Gaudet, MD, PhD
PeerThe Gene Messenger: Advancing Neurological Gene Therapy
Michael Kaplitt, MD, PhD
PeerManaging AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
Steven Nissen, MD
PeerMechanism of Disease: Immunoglobulin A Nephropathy
Mike Sharma, MD, MSc, FRCPC
PeerSevere Asthma: An Exploratory Study on Mucus Plugging
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
Howard C. Herrmann, MD
PeerCMV Infection After Transplant: Who’s at Risk and How to Manage?
Michele Longo, MD
PeerPreventing HIV & Substance Use in Incarcerated Women: Can an App Help?
Key Considerations for CGM Use in Older Adults with T1D
Delivering Transformation: Reducing Maternal Mortality Through Systemic Change
Dena Goffman, MD
PeerConfronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerIdentifying Appropriate Patients for Acute Seizure Treatment
Sheryl Haut, MD
PeerEmpower Your Patients With a Seizure Action Plan
Lawrence Hirsch, MD
PeerDiving into a Treatment for Seizure Clusters Through Patient Case Studies
David Burdette, MD
Peer